// App-Quantinova.ai

EP765 : MODIFICATION OF ESCALATED BEACOPP WITH DACARBAZINE SUBSTITUTION REDUCES TOXICITY WHILE MAINTAINING EFFICACY FOR THE TREATMENT OF ADVANCED-STAGE HODGKIN LYMPHOMA.

Researchers

Presenter

  • Anna Santarsieri

Principal Investigators

  • Pauline Brice

  • Tobias F. Menne

  • Wendy Osborne

  • Thomas Creasey

  • Kirit M. Ardeshna

  • Sarah Behan

  • Kaljit Bhuller

  • Stephen Booth

  • Graham P. Collins

  • Kate Cwynarski

  • Michelle Furtado

  • Sunil Iyengar

  • Stephen G. Jones

  • Deidre O'Mahony

  • Nicolas Martinez-Calle

  • Pamela McKay

  • Sateesh K. Nagumantry

  • John F. Rudge

  • Nimish Shah

  • Gwyneth Stafford

  • Alexander Sternberg

  • Benjamin J. Uttenthal

  • Andrew K. McMillan

  • George A. Follows

Medical Centers

  • Haematology, Oxford University Hospitals, Oxford,United Kingdom

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • University Hospitals Leicester NHS Trust, Leicester, United Kingdom

  • Haematology,Royal Cornwall Hospitals NHS Trust,Cornwall,United Kingdom

  • Haematology,Newcastle University Hospitals NHSFT,Newcastle,United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Bullard Laboratories,University of Cambridge,Cambridge,United Kingdom

  • Paediatrics, Norfolk and Norwich University Hospitals NHS Foundation Trust,Norwich, United Kingdom

  • hématologie biologique,Hôpital Saint Louis,Paris,France

  • Haematology,Peterborough City Hospital - North West Anglia NHS Foundation Trust,Peterborough,United Kingdom

  • Rheumatology, Oxford University Hospitals NHS Foundation Trust, OXFORD, United Kingdom

  • Cork University Hospital, Cork, Ireland

  • Anaesthesia, Great Western Hospitals NHS FoundationTrust, Swindon, United Kingdom

  • Haematology,Sherwood Forest Hospitals NHS Foundation Trust,Nottinghamshire,United Kingdom

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Haematology,Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust,Newcastle,United Kingdom

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Locations

  • United Kingdom

  • France

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • dacarbazine Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved